Law and the Regulation of Medicines

The principal purpose of this book is to tell the story of a medicine’s journey through the regulatory system in the UK, from defining what counts as a medicine, through clinical trials, licensing, pharmacovigilance, marketing and funding. The question of global access to medicines is addressed beca...

Celý popis

Uložené v:
Podrobná bibliografia
Hlavný autor: Jackson, Emily
Médium: E-kniha Kniha
Jazyk:English
Vydavateľské údaje: London Bloomsbury Publishing (UK) 2012
Hart Publishing Ltd
Hart
Bloomsbury Publishing Plc
Bloomsbury Publishing
Hart Publishing
Vydanie:1
Predmet:
Access to health care
Drug accessibility > Great Britain
Drugs
Drugs > Law and legislation > Great Britain
Great Britain
Law
Law and legislation
Legislation
Medical care
Medical Humanities & Medical History
Medical Law and Ethics
Medical research
Medicine
Pharmaceutical industry
Pharmaceuticals
Pharmacology
Pharmacy
Pharmacy > Law and legislation > Great Britain
Public health
Regulation
United Kingdom
ISBN:147420077X, 9781474200776, 9781849461795, 1847319084, 1849461791, 9781847319081
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Obsah:
  • What are Medicines and why are they Special? - Clinical Trials - Licensing - Pharmacovigilance and Liability for Dangerous Drugs - Marketing - Funding and Access to Medicines in the UK - Funding and Access to Medicines - The Future of Medicines I - The Future of Medicines II - Concluding Remarks - Bibliography
  • Law and the regulation of medicines -- Acknowledgements -- Table Of Contents -- Preface -- 1.What are Medicines and why are they Special? -- 2.Clinical Trials -- 3.Licensing -- 4.Pharmacovigilance and Liability for Dangerous Drugs -- 5.Marketing -- 6.Funding and Access to Medicines in the UK -- 7.Funding and Access to Medicines: A Global Problem -- 8.The Future of Medicines I: Pharmacogenetics -- 9.The Future of Medicines II: Enhancement -- Concluding Remarks -- Bibliography.
  • Prelims -- Acknowledgements -- Table of Contents -- Preface -- 1. What are Medicines and why are they Special? -- 2. Clinical Trials -- 3. Licensing -- 4. Pharmacovigilance and Liability for Dangerous Drugs -- 5. Marketing -- 6. Funding and Access to Medicines in the UK -- 7. Funding and Access to Medicines: A Global Problem -- 8. The Future of Medicines I: Pharmacogenetics -- 9. The Future of Medicines II: Enhancement -- Concluding Remarks -- Bibliography